<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">The Global Vaccine Action Plan 2011–2020 (GVAP) is a framework endorsed by the World Health Assembly to improve health by, “Extending the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.” 
 <xref rid="b0005" ref-type="bibr">[1]</xref> In March 2018, the World Health Organization (WHO), the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), and the Bill &amp; Melinda Gates Foundation (BMGF) convened leading scientists, vaccine developers, and public health officials from around the world for the third Global Vaccine and Immunization Research Forum (GVIRF), held in Bangkok, Thailand. As with previous meetings, this GVIRF tracked progress in the GVAP’s research and development agenda, identified opportunities and challenges in meeting GVAP goals, and promoted partnerships in vaccine research 
 <xref rid="b0010" ref-type="bibr">[2]</xref>, 
 <xref rid="b0015" ref-type="bibr">[3]</xref>.
</p>
